Skip to main content
Atrás
Watch Compare

ImageneBio, Inc.

Calidad de datos: 100%
IMA
Nasdaq Manufacturing Chemicals
$4.80
▲ $0.23 (5.03%)
Cap. Mercado: 53.69 M
Precio
$4.80
Cap. Mercado
53.69 M
Rango del Día
$4.51 — $4.90
Rango de 52 Semanas
$3.94 — $18.00
Volumen
15,584
Apertura $4.51
Promedio 50D / 200D
$6.32
24.06% below
Promedio 50D / 200D
$9.32
48.47% below

Quick Summary

Puntos Clave

Revenue declined -59.91% annually over 5 years
Negative free cash flow of -47.84 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 31.36%

Crecimiento

Revenue Growth (5Y)
-59.91%
Below sector avg (1.82%)
Revenue (1Y)-91.27%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-35.47%
Above sector avg (-53.41%)
ROIC-28.50%
Net Margin-5668.63%
Op. Margin-6056.38%

Seguridad

Debt / Equity
N/A
Current Ratio13.24
Interest CoverageN/A

Valoración

PE (TTM)
-1.18
Above sector avg (-1.48)
P/B Ratio0.38
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -1.2 -1.5
P/B 0.4 1.6
ROE % -35.5 -53.4
Net Margin % -5668.6 -41.5
Rev Growth 5Y % -59.9 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -91.27% Revenue Growth (3Y) -70.45%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -59.91% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 800,000.0 Net Income (TTM) -45.35 M
ROE -35.47% ROA -31.60%
Gross Margin N/A Operating Margin -6056.38%
Net Margin -5668.63% Free Cash Flow (TTM) -47.84 M
ROIC -28.50% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 13.24
Interest Coverage N/A Asset Turnover 0.01
Working Capital 136.39 M Tangible Book Value 139.83 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.18 Forward P/E N/A
P/B Ratio 0.38 P/S Ratio 67.11
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -89.11%
Market Cap 53.69 M Enterprise Value -49.47 M
Per Share
EPS (Diluted TTM) -9.64 Revenue / Share 0.07
FCF / Share -4.28 OCF / Share -4.28
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 105.50%
SBC-Adj. FCF -64.20 M Growth Momentum -31.36

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 800,000.0 9.16 M 9.16 M 15.62 M 30.99 M
Net Income -45.35 M -49.23 M -68.17 M -68.77 M -34.12 M
EPS (Diluted) -9.64 -1.02 -1.63 -1.90 —
Gross Profit — — — — —
Operating Income -48.45 M -58.97 M -75.42 M -70.90 M -34.14 M
EBITDA — — — — —
R&D Expenses 28.53 M 30.88 M 59.65 M 64.32 M 47.11 M
SG&A Expenses — — — — —
D&A 400,000.0 — — — —
Interest Expense — — — — —
Income Tax -350,000.0 152,000.0 -162,000.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 152.98 M 141.51 M 192.09 M 172.26 M 247.88 M
Total Liabilities 19.84 M 15.58 M 22.34 M 25.29 M 40.00 M
Shareholders' Equity 133.14 M 125.93 M 169.76 M 146.97 M 207.88 M
Total Debt — — — — —
Cash & Equivalents 94.53 M 39.39 M 119.89 M 59.92 M 232.22 M
Current Assets 140.29 M 127.17 M 178.66 M 160.01 M 236.52 M
Current Liabilities 11.23 M 10.78 M 14.21 M 21.50 M 27.19 M